Celebrating PN awareness week May 4-10, 2025

Clinical Trials

The Foundation for Peripheral Neuropathy helps facilitate clinical research trials on PN. We often connect researchers and industry leaders with a population of PN patients for these trials. Under-enrollment in trials is one of the greatest challenges clinical researchers face as it slows research progress and deters potential funders from investing in research. Across all diseases, 85 percent of clinical trials finish late due to difficulties enrolling participants and nearly one-third of trials fail to recruit a single subject and cannot ever begin.

Start Here

Visit www.clinicaltrials.gov to find active trials or click the button below

A computer decides which patients are in the control group and which patients are in the study group. Patients have a chance of being in either group. The patient and doctor do not decide. It is random and due to chance alone. This helps to avoid bias in the clinical trial. (Bias happens when human choices affect a study’s results.)

In single blind studies, patients do not know whether they are in the control or study group, but the doctor does. In double blind studies, neither the patients nor the doctors know which patients are in each group. (In case of an emergency, doctors can find this information in the study file.)

A placebo is something that looks like medicine, but is not. If a placebo is used, it is given together with the best standard treatment. This allows doctors/researchers to compare standard treatment alone to standard treatment with a new drug.

Help improve the lives of those with PN. Your contribution helps us support research and provide an improved quality of life for those affected.